FNY Investment Advisers’s Verona Pharma VRNA Stock Holding History

FNY Investment Advisers’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-148,120	Closed	-$15.8M	–	1512
2025 Q3	$15.8M	Buy	+148,120	New	+$15.5M	5.08%	1

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

FNY Investment Advisers's VRNA Position: Q4 2025 in Review

FNY Investment Advisers sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 148,120 shares — an estimated $15.8M sold.

FNY Investment Advisers first reported a position in VRNA in Q3 2025 and held it in 1 quarter. The position peaked at $15.8M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

FNY Investment Advisers reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
FNY Investment Advisers sold 148,120 Verona Pharma shares in Q4 2025, an estimated $15.8M.
FNY Investment Advisers first reported a position in Verona Pharma in Q3 2025 and held it in 1 quarter.
FNY Investment Advisers's Verona Pharma position peaked at $15.8M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on FNY Investment Advisers's 13F filing for Q4 2025, filed 16 Jan 2026.